Skip to main content

Read more about our corporate brand here.

Search
Stealth fighter jet soaring above clouds

Strategic Capital

Connect with a dedicated team providing flexible senior and junior debt solutions for the top-performing technology, healthcare and life science companies. We offer large venture debt options, mezzanine term loans and convertible debt instruments for private and public companies.

Select recent transactions
Strong track record partnering with high-growth innovation companies
$35,000,000
Line of Credit and Venture Term Loan
Administrative Agent and Lender
April 2026
Mezzanine Term Loan
Administrative Agent and Lender
January 2026
Line of Credit and Venture Term Loan
Administrative Agent and Lender
January 2026
Venture Term Loan
Administrative Agent and Lender
December 2025
$45,000,000
Growth Capital Term Loan
Administrative Agent and Lender
December 2025
Senior & Mezzanine Term Loan
Administrative Agent & Lender
December 2025
$100,000,000
Venture Term Loan
Administrative Agent and Lender
September 2025
Revolving Credit Facility & Mezzanine Term Loan
Administrative Agent and Lender
September 2025
$50,000,000
Mezzanine Term Loan
Administrative Agent and Lender
April 2025
$25,000,000
Credit Facility
Administrative Agent and Lender
April 2025
$120,000,000
Credit Facility
Administrative Agent and Lender
March 2025
Growth Capital Term Loan
Sole Lender
October 2024
$75,000,000
Mezzanine Term Loan & Revolving Credit Facility
July 2024
$150,000,000
Revolving Line of Credit & Mezzanine Term Loan
Administrative Agent and Primary Bank
June 2024
$17,500,000
Growth Capital Term Loan
Sole Lender
April 2024
Revolving Line of Credit & Mezzanine Term Loan
Administrative Agent
November 2023
Convertible Note
Sole Lender
May 2023
$200,000,000
Mezzanine Term Loan & Revolving Credit Facility
Administrative Agent and Lender
September 2022

Innovator case studies

We support the most innovative companies with debt capital

BigCommerce
E-COMMERCE

BigCommerce

BigCommerce turned to SVB Strategic Capital for capital strategies in 2014, 2017 and 2020 before IPO.

SVB provided:

  • $20 million mezzanine loan and senior debt package prior to Series D.
  • $20 million convertible note to refinance previous mezzanine facility prior to Series F.
  • $35 million second convertible note facility totaling $75 million in credit support in advance of a planned IPO.
  • The runway extension helped management and investor avoid significant dilution, saving the company millions had they raised equity instead.
Icertis
CONTRACT INTELLIGENCE

Icertis

Icertis sought a working capital solution and a more flexible junior facility from various providers to continue investing in business.

SVB provided:

  • $75 million recurring revenue line of credit and a $75 million convertible debt facility strengthened Icertis' enterprise value growth potential, market share and leadership position.
  • Upon an exit, Icertis will have the convertible note eliminated to allow for minimal to no debt as a public company.
Stoke Space
SPACE

Stoke Space

Stoke sought a venture debt solution alongside its equity raise to expand production capacity for the Nova vehicle and complete activation of Launch Complex 14 at Cape Canaveral.

SVB provided:

  • A flexible partnered $100 million venture debt facility to help accelerate the capital initiatives mentioned above.
  • The facility has helped the company and investors avoid significant dilution, which provides material savings had the company raised additional equity instead.

Arming founders and executives with capital solutions

We offer unique financing including senior debt and junior debt to clients. Our streamlined approach, decades of experience and connections across the innovation ecosystem enable us to support your immediate and long-term success.

Deep sector expertise

Access a dedicated team of seasoned professionals with 95+ years of combined industry experience creating tailored loan structures for tech, defense, aerospace, healthcare and life sciences companies.

Flexible debt financing solutions

Achieve financing goals with comprehensive and flexible capital solutions to extend runway, fund equipment or manufacturing, plan an exit and more, with minimal to no equity dilution for existing shareholders prior to a material event.

A streamlined approach

Work with a single lead lender, taking a coordinated approach across senior and junior arrangements for efficient deal approval.

Leaders in flexible financing solutions

$9.6 billion

in financial commitments

442

deals done across technology, life sciences and healthcare

95+

years of combined industry experience

Customized capital strategies

Venture Debt

Extend runway and achieve milestones before raising the next round of equity.

Mezzanine Finance

Avoid dilution before a liquidity event designed to be the last round of capital.

Convertible Debt

Access hybrid debt- and equity-like features and reduce equity dilution with convertible notes prior to an exit.

Pinegrove logo

Our partnership with Pinegrove Venture Partners brings greater access to non-equity funding such as venture debt. Backed by Brookfield and Sequoia Heritage, Pinegrove enables us to offer larger and more flexible loan structures. You'll get to leverage multiple balance sheets while working with a single contact.

Meet your strategic capital partners

Deep expertise and focus on providing flexible financing solutions for technology and healthcare companies

Mike Devery

Mike Devery

Head of Strategic Capital

Tim Walsh

Tim Walsh

Managing Director, Fintech, NorCal and Pacific Northwest

Max Froseth

Max Froseth

Managing Director, Fintech, Central and Southeastern US

Kyle Larrabee

Kyle Larrabee

Director, Frontier Tech, South, Texas and California

Tim Bulakul

Tim Bulakul

Vice President

Ready to talk with our team?

Explore our insights

Access actionable insights and strategic advice to help guide your company's growth.

Report
Innovation in Women's Health Report

Explore the 2026 women's health innovation report: $2 billion in VC funding, AI-driven valuations and where women's health startups are headed.

Report
Healthcare Investments and Exits

Explore the H2 2026 Healthcare Investments & Exits Report. Get data and expert insights on healthcare AI investment, VC funding trends and M&A activity.

BLOG | CASH FLOW MANAGEMENT
Making the most of ISO 20022

Learn the significance of adopting ISO 20022 on the future of data management and payment innovation and how our solutions align with industry standards.

REPORT
Healthtech Trends Report

Discover key insights from the latest healthtech report, including VC investment trends, market innovations and growth in healthcare provider operations.

All third-party trademarks referenced by First Citizens Bank remain the property of their respective owners. First Citizens Bank’s use of third-party trademarks does not indicate any relationship, sponsorship or endorsement between First Citizens Bank and the owners of these trademarks. All references by First Citizens Bank to third-party trademarks are to identify the corresponding third-party goods and services and intended to constitute nominative fair use under applicable trademark laws.

All credit products and loans provided by First-Citizens Bank & Trust Company are subject to underwriting, credit, and collateral approval. Financing availability may vary by state. Restrictions may apply. All information contained herein is for informational purposes only and no guarantee is expressed or implied. Rates, terms, programs, and underwriting policies are subject to change without notice. This is not a commitment to lend. Terms and conditions apply. NMLSR ID 503941
Bank deposit products are offered by First-Citizens Bank & Trust Company. Member FDIC and an Equal Housing Lender.

Strategic Capital
Get in touch
United States
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Ascension
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde Islands
Cayman Islands
Central African Republic
Chad
Chatman Island (New Zealand)
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Croatia
Cuba
Curacao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Easter Island
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Federated States of Micronesia
Fiji
Finland
France
French Antilles
French Guyana
French Polynesia
Fyrom (Macedonia)
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada and Carriacuou
Grenadin Islands
Guadeloupe
Guam
Guantanamo Bay
Guatemala
Guernsey, C.I.
Guiana
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Ivory Coast
Jamaica
Japan
Jersey
Jerusalem
Jordan
Kazakhstan
Kenya
Kiribati
Korea (Rep.)
Korea, Democratic Peoples Republic of
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Mariana Islands
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Midway Islands
Miquelon
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Neth. Antilles
Netherlands
Nevis
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Norway
Oman
Pakistan
Palau
Palistinian Territories
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Principe
Puerto Rico
Qatar
Republic of Macedonia
Republic of Moldova
Reunion Island
Romania
Russia
Rwanda
Saint Martin
Saipan
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal Republic
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Sint Maarten
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
Spain
Sri Lanka
St Pierre et Miquelon
St. Helena
St. Kitts
St. Lucia
St. Vincent
Sudan
Suriname
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
U.S. Virgin Islands
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Wake Island
Wallis and Futuna Islands
Western Samoa
Yemen
Yugoslavia
Zaire
Zambia
Zanzibar
Zimbabwe
By providing your email address, you consent to receive emails from First Citizens Bank. You also consent to the terms of our Privacy Policy. If you have privacy questions, you may contact us at privacyquestions@firstcitizens.com. You can withdraw your consent at any time.
Back to top
You are now leaving First Citizens Innovation Banking

You will be directed to a different website or mobile app that has its own terms of use, visitor agreement, security and privacy policies. First Citizens Innovation Banking is not responsible for (and does not provide) any products, services or content at the third party site or app, except for the products and services that carry the First Citizens Innovation Banking name.